167 related articles for article (PubMed ID: 19580825)
1. Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration.
Hemstapat K; Le L; Edwards SR; Smith MT
Pharmacol Biochem Behav; 2009 Oct; 93(4):498-505. PubMed ID: 19580825
[TBL] [Abstract][Full Text] [Related]
2. Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.
Wright AW; Mather LE; Smith MT
Life Sci; 2001 Jun; 69(4):409-20. PubMed ID: 11459432
[TBL] [Abstract][Full Text] [Related]
3. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
Smith GD; Smith MT
J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
[TBL] [Abstract][Full Text] [Related]
5. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
Long JB; Petras JM; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
[TBL] [Abstract][Full Text] [Related]
6. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice.
Komatsu T; Sakurada S; Katsuyama S; Sanai K; Sakurada T
Int Rev Neurobiol; 2009; 85():207-19. PubMed ID: 19607972
[TBL] [Abstract][Full Text] [Related]
8. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
Shukla VK; Prasad JA; Lemaire S
J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
[TBL] [Abstract][Full Text] [Related]
10. Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
Komatsu T; Sakurada S; Kohno K; Shiohira H; Katsuyama S; Sakurada C; Tsuzuki M; Sakurada T
Biochem Pharmacol; 2009 Oct; 78(8):1026-34. PubMed ID: 19589334
[TBL] [Abstract][Full Text] [Related]
11. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
12. Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide.
Halliday AJ; Bartlett SE; Colditz P; Smith MT
Life Sci; 1999; 65(2):225-36. PubMed ID: 10416828
[TBL] [Abstract][Full Text] [Related]
13. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex.
Bartlett SE; Cramond T; Smith MT
Life Sci; 1994; 54(10):687-94. PubMed ID: 8107513
[TBL] [Abstract][Full Text] [Related]
14. Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones.
Hemstapat K; Monteith GR; Smith D; Smith MT
Anesth Analg; 2003 Aug; 97(2):494-505. PubMed ID: 12873944
[TBL] [Abstract][Full Text] [Related]
15. [Study of Supplementary Analgesics Capable of Reducing the Dosage of Morphine].
Komatsu T
Yakugaku Zasshi; 2016; 136(2):329-35. PubMed ID: 26831810
[TBL] [Abstract][Full Text] [Related]
16. Modulators of pain in the spinal cord.
Jen MF; Lu CH; Huang L; Han JS
NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
[TBL] [Abstract][Full Text] [Related]
17. Effects of A-134974, a novel adenosine kinase inhibitor, on carrageenan-induced inflammatory hyperalgesia and locomotor activity in rats: evaluation of the sites of action.
McGaraughty S; Chu KL; Wismer CT; Mikusa J; Zhu CZ; Cowart M; Kowaluk EA; Jarvis MF
J Pharmacol Exp Ther; 2001 Feb; 296(2):501-9. PubMed ID: 11160637
[TBL] [Abstract][Full Text] [Related]
18. Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-Dawley rats: differences between the tail flick and hot plate nociceptive tests.
South SM; Edwards SR; Smith MT
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):20-8. PubMed ID: 18671713
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of nociception evoked by intrathecal high-dose morphine.
Sakurada T; Komatsu T; Sakurada S
Neurotoxicology; 2005 Oct; 26(5):801-9. PubMed ID: 15936820
[TBL] [Abstract][Full Text] [Related]
20. Biochemical synthesis, purification and preliminary pharmacological evaluation of normorphine-3-glucuronide.
Smith GD; Prankerd RJ; Smith MT
Life Sci; 1997; 61(2):95-104. PubMed ID: 9217268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
